Episode Details

Back to Episodes

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

Published 2 years, 4 months ago

Description

A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.